Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Patients With Acute Infectious Keratoconjunctivitis

NCT05636228 is registered in ClinicalTrials.gov with Invirsa, Inc. as lead sponsor.

NCT NCT05636228
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05636228 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2, Multicenter, Randomized, Double-Masked, Vehicle-Controlled Study of INV-102 Ophthalmic Solution in Patients With Acute Infectious Keratoconjunctivitis
Lead sponsor
Invirsa, Inc.
Phase
Phase 2
Overall status
Completed
Start date
June 9, 2023
Completion date
August 22, 2024
Enrollment
93 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

acute infectious keratoconjunctivitis